Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Liver Injury After Hepatectomy
NCT02833688Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in ischemia-reperfusion injury (IRI), sponsored by Chinese PLA General Hospital. Started Aug 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02833688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02833688.